From: Glutamine, fish oil and antioxidants in critical illness: MetaPlus trial post hoc safety analysis
(epa + dha)/lcf ratio parameters | 6-months mortality | Cox proportional hazard model analysis | |||||
---|---|---|---|---|---|---|---|
Incidence (%) | Coef. | SE | Hazard ratio | 95% CI of the hazard ratio | P value | ||
(epa + dha)/lcf ratio (×10−2), continuous | 0.162 | 0.070 | 1.176 | [1.023, 1.348] | 0.021 | ||
(epa + dha)/lcf ratio (×10−2), recoded to quartiles | |||||||
Q1 cutpoint: <−0.44 | 33 | Q1 versus Q4 | −0.667 | 0.486 | 0.513 | [0.191, 1.324] | 0.170 |
Q2 cutpoints: ≥−0.44 to <0.11 | 35 | Q2 versus Q4 | −0.960 | 0.506 | 0.383 | [0.137, 1.023] | 0.058 |
Q3 cutpoints: ≥0.11 to <3.19 | 48 | Q3 versus Q4 | 0.076 | 0.447 | 1.079 | [0.447, 2.627] | 0.865 |
Q4 cutpoint: ≥3.19 | 46 | ||||||
Overall | 0.105 | ||||||
(epa + dha)/lcf ratio (×10−2), recoded to ≥0 versus <0 | |||||||
<0 | 34 | ≥ 0 versus <0 | 1.030 | 0.383 | 2.800 | [1.344, 6.098] | 0.007 |
≥0 | 46 |